A grand jury returned an indictment yesterday charging Dr. Lesly Pompy, 57, of Monroe, Michigan with unlawful distribution of prescription drugs and health care fraud, United States Attorney Matthew Schneider announced today.
Schneider was joined in the announcement by Special Agent in Charge Timothy J. Plancon, U.S. Drug Enforcement Administration, Detroit Field Division and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services Office of Inspector General’s (HHS-OIG) Chicago Regional Office.
The 37-count Indictment charges that between 2012 and 2016, Dr. Pompy unlawfully distributed more than 4,221,892 dosage units of Schedule II controlled substances and over 6,196,642 total dosage units of all controlled substances outside the course of professional medical practice. During that time frame, he also submitted claims to Medicare, Medicaid and Blue Cross Blue Shield totaling approximately $16,856,683. The majority of these fraudulent claims were seeking reimbursement for the costs of office visits and other services that were not medically necessary and that Dr. Pompy never rendered.
“The damage that the proliferation of opioid distribution has done to our community, like many across the United States has been devastating,” stated United States Attorney Schneider. “It’s particularly disturbing when the distributor is a medical professional
DEA Special Agent in Charge Plancon stated, “This investigation was only possible because of the collaborative efforts of our federal and local law enforcement partners including but not limited to the Monroe Area Narcotics and Investigation Team. The indictment of Pompy reminds the citizens we serve that collectively we are ridding the community of crime one drug dealer at a time.”
Dr. Pompy was arraigned this afternoon in federal court and was released on bond.
This case is being prosecuted by Assistant United States Attorney Brandy R. McMillion and Health Care Fraud Chief Wayne F. Pratt. McMillion serves as the Opioid Fraud Abuse and Detection Unit Prosecutor for the Eastern District of Michigan. This Department of Justice initiative uses data to target and prosecute individuals that are contributing to the nation’s opioid crisis. The Eastern District of Michigan is one of the twelve districts included in the Opioid Fraud Abuse and Detection Unit.
The case was investigated by the U.S. Drug Enforcement Administration and the U.S. Department of Health and Human Services, Office of Inspector General.
An indictment is only a charge and is not evidence of guilt. Each defendant is entitled to a fair trial in which it will be the government’s burden to prove guilt beyond a reasonable doubt.